Credo Technology

No trajectory update has cleared publication yet.

• The filing does not establish whether any of the FY27 CEO PSU revenue or stock-price hurdles will be achieved.
• The filing does not provide an independent assessment of the company’s strategic plan or the award’s eventual economic cost to shareholders.
• The filing reports the award structure but does not state the current market value of any unearned FY27 CEO PSUs.
• The filings do not state why either executive sold shares or how sale proceeds will be used.
• The filings do not establish whether the sales indicate a change in the executives' outlook for Credo.
• The combined gross transaction value is calculated from reported quantities and weighted-average prices; net proceeds are unknown.
• The filings do not provide an independent explanation of the executives' remaining economic exposure beyond the reported holdings and trust disclosures.
• The complete aggregate proceeds from all reported sale lots.
• Whether additional sales occurred outside the reported lots.
• The seller’s motivation and the trust’s remaining economic exposure beyond the reported share count.
• The total proceeds from the multiple transactions.
• The relationship between Zhan BVI Co. Ltd. and the Cheng Huang Family Trust beyond the filing’s indirect-ownership disclosure.
• The filer’s reason for selling.
• Whether the proposed 275,000-share sale was completed.
• The final execution price and proceeds.
• The trust's ownership after the proposed sale.
• Whether the proposed sale is part of the same continuing 10b5-1 program as the listed prior sales.
• The total proceeds from the CFO's series of sales.
• The tax rates and withholding obligations underlying the CEO and COO transactions.
• The CFO's total remaining direct and indirect ownership after the reported transactions.
• Whether James Laufman's 5,000-share sale was made under a Rule 10b5-1 plan.
• The filing does not disclose the specific hyperscale customers responsible for the AEC ramp.
• The filing does not provide a standalone revenue, profit or cash-flow contribution for Hyperlume, Comira or DustPhotonics.
• The filing does not provide the final value or probability-weighted outcome of the contingent DustPhotonics consideration.
• The filing does not establish the post-acquisition timing for DustPhotonics integration or quantify expected synergies.
• The filing does not provide customer purchase commitments supporting the reported AEC growth; substantially all product sales are described as purchase-order based.
• The total dollar proceeds from the CTO-linked trust transactions.
• The CTO's and trust's broader post-transaction economic exposure beyond the reported holdings.
• Whether the director sale and trust sales were related in timing or purpose.
• The reason for the sales beyond the stated trading plan.
• Whether either proposed sale was completed.
• The option exercise price, tax withholding, and net proceeds associated with Fleming's cashless exercise.
• The officers' post-sale holdings and the final execution prices.
• Whether the two officers acted under related or independent plans.
• The aggregate proceeds from Brennan’s multiple sale lines.
• The purpose and trading-plan status of the sales.
• The extent of Brennan’s pecuniary interest in the family-trust shares.
• Whether additional insiders made related sales outside the packet.
• The award agreement had not yet been filed in the packet; the filing says it will be included with the quarterly report for the quarter ending August 2, 2026.
• The filing does not provide the grant-date fair value or expected compensation expense.
• The filing does not establish whether any tranche will ultimately vest.
• Expected closing date and conditions to completion.
• Credo's source of cash and effect on liquidity or debt.
• DustPhotonics revenue, profitability, products, and customer concentration.
• The financial milestones governing the potential issuance of up to approximately 3.21 million additional shares.
• Expected synergies and integration costs.
• The filings do not state the aggregate dollar proceeds from all reported sales.
• The filings do not state whether the Rule 10b5-1 plans remain active or how many shares remain scheduled for sale.
• The filings do not explain the executives' reasons for selling.
• The filings do not provide operating results, guidance, valuation context, or market-reaction data.
• The packet does not include Exhibit 99.1 to the September 1, 2026 Form 8-K, so the exact press-release guidance and management commentary accompanying the results are unavailable.
• The packet does not provide final post-acquisition operating results attributable to DustPhotonics separately from Credo’s consolidated results.
• The DustPhotonics purchase price allocation is preliminary; the filing states that the primary areas remaining preliminary include certain acquired intangible assets, contingent consideration, income tax including deferred taxes, and residual goodwill.
• The packet does not provide order value, backlog conversion or deployment timing for the hyperscale customer ramps.
• The packet does not provide aggregate proceeds for either insider across all weighted-average tranches.
• The packet does not provide the director's plan-adoption date or indirect holdings.
• The packet does not provide contemporaneous Credo operating results or market reaction.
• The filing does not disclose the total proceeds from the reported sales.
• The filing does not disclose whether the transactions changed the family's aggregate economic exposure beyond the reported post-transaction holdings.
• The packet does not provide aggregate proceeds for the eight transaction blocks.
• The packet does not establish the trust's total economic interest attributable to the reporting person.
• The packet does not disclose the reason for the sale.
• The packet does not provide the aggregate proceeds for either executive's complete set of transactions.
• The packet does not disclose the executives' reasons for selling or whether the plans were modified or terminated.
• The packet does not establish whether the sales were connected to taxes, diversification or other personal liquidity needs.
• The filing does not state the exact gross proceeds for the aggregate 111,220 shares.
• The filing does not disclose whether the planned sales are complete or whether additional sales remain under the trading plan.
• The Form 4 does not state whether the sale was for tax withholding or another purpose.
• The filing does not provide the officer's complete economic exposure across indirect holdings and derivative securities.
• The packet does not provide subsequent ownership filings or management commentary.